NM_001372327.1:c.20C>T
Variant names:
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3
The NM_001372327.1(SLC29A1):c.20C>T(p.Pro7Leu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as (no stars).
Frequency
Genomes: not found (cov: 33)
Consequence
SLC29A1
NM_001372327.1 missense
NM_001372327.1 missense
Scores
3
11
4
Clinical Significance
Conservation
PhyloP100: 4.38
Publications
0 publications found
Genes affected
SLC29A1 (HGNC:11003): (solute carrier family 29 member 1 (Augustine blood group)) This gene is a member of the equilibrative nucleoside transporter family. The gene encodes a transmembrane glycoprotein that localizes to the plasma and mitochondrial membranes and mediates the cellular uptake of nucleosides from the surrounding medium. The protein is categorized as an equilibrative (as opposed to concentrative) transporter that is sensitive to inhibition by nitrobenzylthioinosine (NBMPR). Nucleoside transporters are required for nucleotide synthesis in cells that lack de novo nucleoside synthesis pathways, and are also necessary for the uptake of cytotoxic nucleosides used for cancer and viral chemotherapies. Multiple alternatively spliced variants, encoding the same protein, have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.744
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001372327.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC29A1 | NM_001372327.1 | MANE Select | c.20C>T | p.Pro7Leu | missense | Exon 2 of 13 | NP_001359256.1 | Q99808-1 | |
| SLC29A1 | NM_001304462.2 | c.257C>T | p.Pro86Leu | missense | Exon 3 of 14 | NP_001291391.1 | Q99808-2 | ||
| SLC29A1 | NM_001304465.2 | c.98C>T | p.Pro33Leu | missense | Exon 2 of 13 | NP_001291394.1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC29A1 | ENST00000371755.9 | TSL:1 MANE Select | c.20C>T | p.Pro7Leu | missense | Exon 2 of 13 | ENSP00000360820.3 | Q99808-1 | |
| SLC29A1 | ENST00000371708.1 | TSL:1 | c.20C>T | p.Pro7Leu | missense | Exon 1 of 12 | ENSP00000360773.1 | Q99808-1 | |
| SLC29A1 | ENST00000393844.7 | TSL:1 | c.20C>T | p.Pro7Leu | missense | Exon 2 of 13 | ENSP00000377427.1 | Q99808-1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 30
GnomAD4 exome
Cov.:
30
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
ClinVar submissions
View on ClinVar Significance:Other
Revision:
Pathogenic
VUS
Benign
Condition
-
-
-
Squamous cell carcinoma of the head and neck (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Benign
D
MetaRNN
Pathogenic
D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Uncertain
Sift
Benign
D
Sift4G
Uncertain
D
Polyphen
P
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.